By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.
Founded in 2022 with a registered capital of 8 million RMB, Huiqing Information Technology focuses on software and information technology services. The patent obtained involves a smart IoT gateway ...
According to Securities Star, data from Qichacha shows that Foton Motor (600166) has announced an international patent ...
Subject matter eligibility has been the most confounding and unpredictable issue in patent law since the Alice decision ...
The debate over quarterly versus semi-annual earnings reporting has resurfaced, with President Trump suggesting a move to ...
Most days, preparing and prosecuting patent applications follows a familiar rhythm. Talk with the inventors. Draft the ...
The approval strengthens Nanexa's patent portfolio, with additional patent applications filed in other strategically important countries Nanexa announces that a key patent application has been granted ...
The ongoing policy debate about pharmaceutical and biologic patents has been coopted by those who don’t like ...
The key is to match the protection method to the aspects of your product that drive value. Consider combining strategies for ...
But, according to a new global ranking of 139 economies published by the World Intellectual Property Office (WIPO), Germany ...
Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...
Virtual store tool uses synced camera feeds, sensors and AI to monitor shopping behavior down to the shelf level ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback